VYNE Therapeutics Inc. (VYNE)
NASDAQ
$0.81+6.15%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 2,225,144
- 52-week high
- —
- 52-week low
- —
- Open
- $0.77
- Day high
- $0.82
- Day low
- $0.75
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $570K | -$26.48M | -$0.62 |
| 2024 | $501K | -$39.83M | -$0.93 |
| 2023 | $424K | -$28.45M | -$2.78 |
| 2022 | $477K | -$23.21M | -$7.28 |
| 2021 | $931K | -$73.33M | -$25.64 |
About VYNE Therapeutics Inc.
A company overview for VYNE Therapeutics Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is VYNE Therapeutics Inc.'s stock price today?
- VYNE is trading at $0.81 as of Jul 20, 2026.
- Does VYNE Therapeutics Inc. pay a dividend?
- VYNE Therapeutics Inc. did not pay a dividend in its most recent reported fiscal year.